Similarly, expression of RING domain-deficient BRCA1 (Rdd-BRCA1) has been observed in mammary tumours of mice carrying the BRCA185stop founder mutation which does not require interaction with BARD1 for protein stability, enabling normal HR function in the presence of PARP inhibition [22]. Here, PARP1 is linked to breast cancer.